Total Payments
$2,816
2024 Payments
$889.35
Companies
26
Transactions
86
Medicare Patients
1,356
Medicare Billing
$241,205
Payment Breakdown by Category
Food & Beverage$2,766 (98.2%)
Education$50.10 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,766 | 82 | 98.2% |
| Education | $50.10 | 4 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $388.50 | 12 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $339.38 | 7 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $307.99 | 11 | $0 (2024) |
| Tempus AI, Inc | $231.18 | 4 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $169.33 | 3 | $0 (2024) |
| Genentech USA, Inc. | $145.77 | 7 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $142.72 | 2 | $0 (2023) |
| Celgene Corporation | $141.12 | 5 | $0 (2024) |
| PUMA BIOTECHNOLOGY, INC. | $138.13 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $137.38 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $889.35 | 28 | Dendreon Pharmaceuticals LLC ($307.99) |
| 2023 | $445.77 | 9 | Bayer Healthcare Pharmaceuticals Inc. ($119.92) |
| 2022 | $186.22 | 5 | Janssen Biotech, Inc. ($79.04) |
| 2021 | $309.41 | 9 | E.R. Squibb & Sons, L.L.C. ($108.94) |
| 2020 | $277.57 | 8 | E.R. Squibb & Sons, L.L.C. ($119.92) |
| 2019 | $31.84 | 2 | AbbVie, Inc. ($17.00) |
| 2018 | $414.97 | 9 | Astellas Pharma US Inc ($124.99) |
| 2017 | $260.50 | 16 | Novartis Pharmaceuticals Corporation ($59.20) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $28.89 | General |
| 12/10/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/31/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $32.52 | General |
| Category: Hematology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TALVEY (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $39.72 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/12/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $25.44 | General |
| 08/14/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.86 | General |
| Category: Oncology | ||||||
| 08/02/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/27/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $7.99 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/27/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $1.93 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 07/26/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $147.91 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/18/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/06/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $89.25 | General |
| 05/23/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 05/09/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: ONCOLOGY | ||||||
| 04/30/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $20.31 | General |
| 04/24/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $32.28 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $28.67 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 03/29/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: ONCOLOGY | ||||||
| 03/25/2024 | Ethicon US, LLC | STRATAFIX (Device) | Food and Beverage | In-kind items and services | $35.54 | General |
| Category: Wound Closure | ||||||
| 03/01/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $26.02 | General |
| Category: Hematology | ||||||
| 02/29/2024 | Tempus AI, Inc | XT CDX (Device) | Food and Beverage | In-kind items and services | $87.60 | General |
| Category: NONE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 377 | 791 | $215,599 | $67,133 |
| 2022 | 6 | 288 | 653 | $184,540 | $56,167 |
| 2021 | 10 | 343 | 718 | $202,854 | $65,370 |
| 2020 | 9 | 348 | 663 | $164,175 | $52,536 |
Total Patients
1,356
Total Services
2,825
Medicare Billing
$241,205
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 155 | 363 | $104,544 | $26,703 | 25.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 32 | 112 | $25,536 | $11,333 | 44.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 114 | $18,012 | $7,666 | 42.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 31 | $13,671 | $4,610 | 33.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 28 | 28 | $13,664 | $4,277 | 31.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 28 | 35 | $14,000 | $4,176 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 50 | $14,400 | $3,939 | 27.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 32 | $9,536 | $3,328 | 34.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 26 | $2,236 | $1,100 | 49.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 139 | 361 | $103,968 | $27,877 | 26.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 145 | $33,060 | $12,718 | 38.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 22 | $9,702 | $3,694 | 38.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 23 | 23 | $11,224 | $3,431 | 30.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 16 | 25 | $10,000 | $3,031 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 28 | 34 | $9,792 | $2,843 | 29.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 43 | $6,794 | $2,572 | 37.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 117 | 310 | $86,272 | $24,870 | 28.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 44 | 150 | $34,200 | $13,058 | 38.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 43 | 98 | $37,275 | $12,227 | 32.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 22 | $9,702 | $3,807 | 39.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 25 | 25 | $9,190 | $2,661 | 29.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 22 | 38 | $6,004 | $2,236 | 37.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 14 | 14 | $6,802 | $2,094 | 30.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 15 | $4,470 | $1,761 | 39.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 19 | 19 | $4,180 | $1,638 | 39.2% |
About Dr. Jonathan Blitzer, MD
Dr. Jonathan Blitzer, MD is a Specialist healthcare provider based in Long Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912967324.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Blitzer, MD has received a total of $2,816 in payments from pharmaceutical and medical device companies, with $889.35 received in 2024. These payments were reported across 86 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,766).
As a Medicare-enrolled provider, Blitzer has provided services to 1,356 Medicare beneficiaries, totaling 2,825 services with total Medicare billing of $241,205. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Hematology & Oncology
- Location Long Beach, CA
- Active Since 03/28/2006
- Last Updated 01/03/2018
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1912967324
Products in Payments
- PROVENGE (Drug) $307.99
- OPDIVO (Biological) $302.16
- Nubeqa (Drug) $169.33
- DARZALEX (Biological) $146.65
- TAGRISSO (Drug) $142.72
- XTANDI (Drug) $124.99
- Nerlynx (Drug) $117.82
- REBLOZYL (Biological) $91.37
- XT CDX (Device) $87.60
- IMBRUVICA (Drug) $78.61
- EPKINLY (Drug) $58.19
- KEYTRUDA (Biological) $54.16
- ERLEADA (Drug) $50.00
- Pomalyst (Drug) $49.75
- QINLOCK (Drug) $48.09
- TECVAYLI (Biological) $44.71
- TALVEY (Biological) $39.72
- OPDUALAG (Drug) $37.22
- STRATAFIX (Device) $35.54
- Enhertu (Drug) $32.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Long Beach
David Morrison, M.d, M.D
Specialist — Payments: $4.9M
Specialist $4.9M
Peter Kurzweil, M.d, M.D
Specialist — Payments: $511,121
Specialist $511,121
Dan Tran, M.d, M.D
Specialist — Payments: $394,164
Specialist $394,164
Dr. David Shavelle, M.d, M.D
Specialist — Payments: $88,220
Specialist $88,220
Philip Yuan, M.d, M.D
Specialist — Payments: $59,461
Specialist $59,461
Dr. Nilesh Vora, M.d, M.D
Specialist — Payments: $18,049
Specialist $18,049